Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-13

Clinical Trial Update: Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating epacadostat given before surgery in newly diagnosed, advanced ovarian, fallopian tube, or primary peritoneal cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epacadostat (epacadostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7 | EARLY_Phase 1 | Status: COMPLETED